Solid tissues removed from Atm homozygous deficient mice do not exhibit a mutator phenotype for second-step autosomal mutations

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4781-4783

  Turker, Mitchell S ^a   Gage, Blythe M ^a   Rose, Jennifer A ^a   Ponomareva, Olga N ^a   Tischfield, Jay A ^d   Stambrook, Peter J ^e   Barlow, Carrolee ^b,f   Wynshaw Boris, Anthony ^c,f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; DNA DAMAGE; EAR; FEMALE; GENE MUTATION; KIDNEY EPITHELIUM; KNOCKOUT GENE; MALE; MESENCHYME; MOUSE; MUTATOR GENE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ADENINE PHOSPHORIBOSYLTRANSFERASE; ANIMALS; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CHROMOSOME MAPPING; DNA-BINDING PROTEINS; EAR; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MUTATION; ORGAN SPECIFICITY; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033213967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hecht, F., and Hecht, B. K. Cancer in ataxia-telangiectasia patients. Cancer Genet. Cytogenet., 46: 9-19, 1990.
2. Meyn, M. S. Chromosome instability syndromes: lessons for carcinogenesis. Curr. Top. Microbiol. Immunol., 227: 71-148, 1997.
3. Steingrimsdottir, H., Rowley, G., Waugh, A., Beare, D., Ceccherini, I., Cole, J., and Lehmann, A. R. Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutat. Res., 294: 29-41, 1993.
4. Cole, J., and Arlett, C. F. Cloning efficiency and spontaneous mutant frequency in circulating T-lymphocytes in ataxia-telangiectasia patients. Int. J. Radiat. Biol., 66: S123-S131, 1994.
5. Bigbee, W. L., Langlois, R. G., Swift, M., and Jensen, R. H. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am. J. Hum. Genet., 44: 402-408, 1989.
6. Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med., 325: 1831-1836, 1991.
7. Stankovic, T., Weber, P., Stewart, G., Bedenham, T., Murray, J., Byrd, P. J., Moss, P. A., and Taylor, A. M. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet, 353: 26-29, 1999.
8. Bishop, D. T., and Hopper, J. AT-tributable risks? Nat. Genet, 15: 226, 1997.
9. Inskip, H. M., Kinlen, L. J., Taylor, A. M., Woods, C. G., and Arlett, C. F. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br. J. Cancer. 79: 1304-1307, 1999.
10. Swift, M., and Su, Y. Link between breast cancer and ATM gene is strong. BMJ, 318: 400, 1999.
11. Stambrook, P. J., Shao, C., Stockelman, M., Boivin, G., Engle, S. J., and Tischfield, J. A. APRT: a versatile in vivo resident reporter of local mutation and loss of heterozygosity. Environ. Mol. Mutagen., 28, 471-482, 1996.
12. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M , Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw-Boris, A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86: 159-171, 1996.
13. Horn, P. L., Turker, M. S., Ogburn, C. E., Disteche, C. M., and Martin, G. M. A cloning assay for 6-thioguanine resistance provides evidence against certain somatic mutational theories of aging. J. Cell Physiol., 121: 309-315, 1984.
14. Turker, M. S., Gage, B. M., Rose, J. A., Elroy, D., Ponomareva, O. N., Stambrook, P. J., and Tischfield, J. A. A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers. Cancer Res., 59: 1837-1839, 1999.
15. Shao, C., Deng, L., Henegariv, O., Liang, L., Raikwar, N., Sahota, A., Stambrook, P. J., and Tischfield, J. A. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc. Natl. Acad. Sci. USA, 96: 9230-9235, 1999.
16. Rotman, G., and Shiloh, Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? BioEssays, 19: 911-917, 1997.
17. Cooper, G. E., Khattar, N. H., Bishop, P. L., and Turker, M. S. At least two distinct epigenetic mechanisms are correlated with high frequency "switching" for APRT phenotypic expression in mouse embryonal carcinoma stem cells. Somatic Cell Mol. Genet., 18: 215-226, 1992.
18. Elson, A., Wang, Y., Daugherty, C. J., Morton, C. C., Zhou, F., Campos-Torres, J., and Leder, P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA, 93: 13084-13089, 1996.